![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print March 29, 2007
Washington University School of Medicine, St. Louis, MO 63110
Corresponding Author: emajerus{at}im.wustl.edu
ADAMTS13 is a plasma metalloproteinase that cleaves von Willebrand Factor to smaller less thrombogenic forms. Deficiency of ADAMTS13 activity in plasma leads to thrombotic thrombocytopenic purpura. ADAMTS13 contains eight thrombospondin type 1 repeats (TSR), seven of which contain a consensus sequence for the direct addition of fucose to the hydroxyl group of serine or threonine. Mass spectral analysis of tryptic peptides derived from human ADAMTS13 indicate that at least six of the TSRs are modified with an O-fucose disaccharide. Analysis of [3H]fucose metabolically incorporated into ADAMTS13 demonstrated that the disaccharide has the structure Glucose-
J. Biol. Chem, 10.1074/jbc.M700317200
Submitted on January 11, 2007
Revised on March 29, 2007
Accepted on March 29, 2007
O-Fucosylation is required for ADAMTS13 secretion
1,3-Fucose. Mutation of the modified serine to alanine in TSRs 2, 5 and 7 reduced the secretion of ADAMTS13. Mutation of more than one site dramatically reduced secretion regardless of the sites mutated. When the expression of protein O-fucosyltransferase 2 (POFUT2), the enzyme that transfers fucose to serines in TSRs, was reduced using siRNA, the secretion of ADAMTS13 decreased. A similar outcome was observed when ADAMTS13 was expressed in a cell line unable to synthesize the donor for fucose addition, GDP-fucose. While overexpression of POFUT2 did not affect the secretion of wild-type ADAMTS13, it did increase the secretion of the ADAMTS13 TSR 1,2 double mutant but not that of ADAMTS13 TSR 1-8 mutant. Together these findings indicate that O-fucosylation is functionally significant for secretion of ADAMTS13.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Zhou, L. W. Li, Q. Yan, B. Petryniak, Y. Man, C. Su, J. Shim, S. Chervin, and J. B. Lowe Notch-dependent control of myelopoiesis is regulated by fucosylation Blood, July 15, 2008; 112(2): 308 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Gebauer, S. Muller, F.-G. Hanisch, M. Paulsson, and R. Wagener O-Glucosylation and O-Fucosylation Occur Together in Close Proximity on the First Epidermal Growth Factor Repeat of AMACO (VWA2 Protein) J. Biol. Chem., June 27, 2008; 283(26): 17846 - 17854. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stahl, K. Uemura, C. Ge, S. Shi, Y. Tashima, and P. Stanley Roles of Pofut1 and O-Fucose in Mammalian Notch Signaling J. Biol. Chem., May 16, 2008; 283(20): 13638 - 13651. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hess, J. J. Keusch, S. A. L. Oberstein, R. C. M. Hennekam, and J. Hofsteenge Peters Plus Syndrome Is a New Congenital Disorder of Glycosylation and Involves Defective O-Glycosylation of Thrombospondin Type 1 Repeats J. Biol. Chem., March 21, 2008; 283(12): 7354 - 7360. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |